Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
About this item
Full title
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Author / Creator
Journal title
The New England journal of medicine, 2015-11, Vol.373 (22), p.2117-2128
Language
English
Formats
More information
Alternative Titles
Full title
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_citationtrail_10_1056_NEJMoa1504720
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_citationtrail_10_1056_NEJMoa1504720
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1504720
How to access this item
Log in as a Library member